Riluzole, an SLC7A11 inhibitor used to manage ALS (Amyotrophic lateral sclerosis), and sulfasalazine, which is used to treat IBD (inflammatory bowel disease) and arthritis were also identified as potential candidates. The gene discussed is SLC7A11; the disease is arthritic joint disease.